Zorzon M - Search Results

1

Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature.

Zivadinov R, Zorzon M. Zivadinov R, et al. Among authors: zorzon m. J Neuroimaging. 2002 Oct;12(4):302-9. doi: 10.1111/j.1552-6569.2002.tb00137.x. J Neuroimaging. 2002. PMID: 12380476 Review.

2

Sexual dysfunction in multiple sclerosis: a MRI, neurophysiological and urodynamic study.

Zivadinov R, Zorzon M, Locatelli L, Stival B, Monti F, Nasuelli D, Tommasi MA, Bratina A, Cazzato G. Zivadinov R, et al. Among authors: zorzon m. J Neurol Sci. 2003 Jun 15;210(1-2):73-6. doi: 10.1016/s0022-510x(03)00025-x. J Neurol Sci. 2003. PMID: 12736092

3

HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis.

Zivadinov R, Uxa L, Zacchi T, Nasuelli D, Ukmar M, Furlan C, Pozzi-Mucelli R, Tommasi MA, Locatelli L, Ulivi S, Bratina A, Bosco A, Grop A, Cazzato G, Zorzon M. Zivadinov R, et al. Among authors: zorzon m. J Neurol. 2003 Sep;250(9):1099-106. doi: 10.1007/s00415-003-0164-7. J Neurol. 2003. PMID: 14504973

4

Normalized regional brain atrophy measurements in multiple sclerosis.

Zivadinov R, Locatelli L, Stival B, Bratina A, Grop A, Nasuelli D, Brnabic-Razmilic O, Zorzon M. Zivadinov R, et al. Among authors: zorzon m. Neuroradiology. 2003 Nov;45(11):793-8. doi: 10.1007/s00234-003-1101-2. Epub 2003 Oct 10. Neuroradiology. 2003. PMID: 14551760

5

A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a.

Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L, Cazzato G. Zivadinov R, et al. Among authors: zorzon m. J Neurol Sci. 2003 Dec 15;216(1):113-8. doi: 10.1016/s0022-510x(03)00225-9. J Neurol Sci. 2003. PMID: 14607312

6

MMP-9 microsatellite polymorphism and multiple sclerosis.

Fiotti N, Zivadinov R, Altamura N, Nasuelli D, Bratina A, Tommasi MA, Bosco A, Locatelli L, Grop A, Cazzato G, Guarnieri G, Giansante C, Zorzon M. Fiotti N, et al. Among authors: zorzon m. J Neuroimmunol. 2004 Jul;152(1-2):147-53. doi: 10.1016/j.jneuroim.2004.03.009. J Neuroimmunol. 2004. PMID: 15223247

7

Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.

Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M. Zivadinov R, et al. Among authors: zorzon m. J Neurol Sci. 2004 Aug 30;223(2):185-93. doi: 10.1016/j.jns.2004.05.010. J Neurol Sci. 2004. PMID: 15337621

8

Frontal parenchymal atrophy measures in multiple sclerosis.

Locatelli L, Zivadinov R, Grop A, Zorzon M. Locatelli L, et al. Among authors: zorzon m. Mult Scler. 2004 Oct;10(5):562-8. doi: 10.1191/1352458504ms1093oa. Mult Scler. 2004. PMID: 15471374

9

Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.

Zivadinov R, Grop A, Sharma J, Bratina A, Tjoa CW, Dwyer M, Zorzon M. Zivadinov R, et al. Among authors: zorzon m. J Neuroimaging. 2005 Jan;15(1):27-36. doi: 10.1177/1051228404271010. J Neuroimaging. 2005. PMID: 15574571

10

Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.

Zivadinov R, Zorzon M, De Masi R, Nasuelli D, Cazzato G. Zivadinov R, et al. Among authors: zorzon m. J Neurol Sci. 2008 Apr 15;267(1-2):28-35. doi: 10.1016/j.jns.2007.09.025. Epub 2007 Oct 18. J Neurol Sci. 2008. PMID: 17945260 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page